Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Serum Catestatin in Acne Vulgaris Treated with Isotretinoin
NCT07054398Recruiting
- Sponsor
- Aswan University
- Start
- Jan 2025
- Primary completion
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of isotretinoin in acne vulgaris (2 arms), sponsored by Aswan University. Primary endpoints: Serum Catestatin Level at 12 weeks and Effect of treatment with systemic isotretinoin at 12 weeks. Started Jan 2025; status: recruiting.
02
Drugs
isotretinoin
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT07054398.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07054398.